MetaVia Inc., a clinical-stage biotechnology company, focuses on developing novel pharmaceuticals to treat cardiometabolic diseases. The company develops DA-1241, a novel G-Protein-Coupled Receptor 119 agonist with development optionality a...
Leadership
Hyung Heon Kim
CEO, President & Director
Marshall H. Woodworth
Chief Financial Officer
Mi-Kyung Kim
Chief Scientific Officer
Robert Homolka
Senior Vice President of Clinical Operations
W. Christopher Fang M.D.
Consulting Chief Medical Officer & Advisor
Michael C. Pine
Senior Vice President of Business Development Advisor
